Actinium Pharmaceuticals, Inc.ATNMNYSE
Loading
Year-over-year net income growth rate
5Y CAGR
+23.9%/yr
Long-term compound
Percentile
P86
Within normal range
vs 5Y Ago
2.9x
Strong expansion
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2024 | 21.66% |
| 2023 | -47.86% |
| 2022 | -33.27% |
| 2021 | -11.52% |
| 2020 | -1.44% |
| 2019 | 7.42% |
| 2018 | 11.08% |
| 2017 | -9.37% |
| 2016 | -15.68% |
| 2015 | 14.84% |